Edit |   |
---|---|
Antigenic Specificity | CD200, Human (Samalizumab biosimilar) |
Clone | Samalizumab |
Host Species | Recombinant Mouse |
Reactive Species | human |
Isotype | IgG2-G4 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | IF, IP, Neut, FuncS, ELISA, FCM, WB |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD200 Recombinant Antibody. Samalizumab is a humanized monoclonal antibody designed for oncology indications. Samalizumab was developed by Alexion Pharmaceuticals. |
Immunogen | n/a |
Other Names | Anti-CD200 Recombinant Antibody, Research Grade Samalizumab, Anti-Human CD200 Recombinant Antibody, ALXN6000, Anti-CD200, hB7V3V2 G2G4, Antibody Drug Analogues, Monoclonal Antibody, YR1237, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1073059-33-2 |
Catalog # | YR1237 |
Price | please inquire |
Order / More Info | CD200, Human (Samalizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |